Based on clinical experience, regular monitoring of parameters of iron metabolism should be performed at least monthly for patients in the initial treatment stage, and at least every 3 months for patients in the maintenance treatment stage of anemia or those with stable Hb. This evidence concerns the gene GSTM1 and anemia (phenotype).